Cargando…

Clozapine blood level assessment using a point-of-care device: feasibility and reliability

BACKGROUND: Therapeutic drug monitoring (TDM) is useful to assess clozapine adherence and optimize treatment. However, analysis of venous blood levels by liquid chromatography tandem mass spectrometry (LC-MS/MS) is often logistically complicated and process time is prolonged. OBJECTIVE: To assess th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamhi-Nesher, Shiri, Taub, Sharon, Halimi, Shikma, Frenkel, Maria, Azam, Mahmud, Bormant, Gil, Isakov, Helena, Radzinsky, Dikla, Weizman, Abraham, Krivoy, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201354/ https://www.ncbi.nlm.nih.gov/pubmed/35720508 http://dx.doi.org/10.1177/20451253221094435

Ejemplares similares

Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial
por: Krivoy, Amir, et al.
Publicado: (2017)

Trends of new-onset psychosis or mania in psychiatric emergency departments during the COVID19 pandemic: a longitudinal comparative study
por: Segev, Aviv, et al.
Publicado: (2021)

S41. SHORT- AND LONG-TERM OUTCOMES OF VITAMIN D SUPPLEMENTATION IN CLOZAPINE TREATED CHRONIC SCHIZOPHRENIA PATIENTS
por: Krivoy, Amir, et al.
Publicado: (2018)

Predicting Affect Classification in Mental Status Examination Using Machine Learning Face Action Recognition System: A Pilot Study in Schizophrenia Patients
por: Barzilay, Ran, et al.
Publicado: (2019)

M152. IS MEDICAL SERVICES UTILISATION A MODERATING FACTOR OF EARLY EXCESS MORTALITY IN PATIENTS WITH SCHIZOPHRENIA
por: Krivoy, Amir, et al.
Publicado: (2020)

Rapid-onset clozapine-induced loss of glycaemic control: case report
por: Porras-Segovia, Alejandro, et al.
Publicado: (2017)

Clozapine Suppresses the Gene Expression and the Production of Cytokines and Up-Regulates Cyclooxygenase 2 mRNA in Human Astroglial Cells
por: Yuhas, Yael, et al.
Publicado: (2022)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

Impact of polypharmacy on inducing blood dyscrasias in clozapine treated patients
por: Shiri, M., et al.
Publicado: (2022)

Incidence of clozapine-induced hematological side effects in a Tunisian population
por: Shiri, M., et al.
Publicado: (2022)

Dealing With Clozapine-Induced Sialorrhea
por: Sá Couto, J., et al.
Publicado: (2022)

Clozapine in pregnancy
por: Sethi, Sujata
Publicado: (2006)

Clozapine is underutilized
por: Kane, John M.
Publicado: (2012)

Clozapine cessation
por: Ktari, H., et al.
Publicado: (2022)

An international clozapine titration guideline for clozapine: An opportunity for moving forward on personalizing clozapine treatment in India and other countries
por: de Leon, Jose
Publicado: (2022)

Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users
por: Cohen, Koby, et al.
Publicado: (2020)

Development of point-of-care testing devices to improve clozapine prescribing habits and patient outcomes
por: Kalaria, Shamir N, et al.
Publicado: (2019)

T203. RELEVANT CLOZAPINE BLOOD LEVELS USING A POINT OF CARE TEST (POCT)
por: Kelly, Deanna, et al.
Publicado: (2020)

Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)
por: Kitagawa, Kohei, et al.
Publicado: (2020)

Successful Clozapine Re-Challenge After Suspected Clozapine-Induced Myocarditis
por: Hosseini, Seyed Alireza, et al.
Publicado: (2020)

Clozapine point of care testing in acute psychiatry: A precision approach to treatment resistant psychosis
por: Boland, X., et al.
Publicado: (2021)

Clozapine induced eosinophilia
por: Majumder, Pradipta, et al.
Publicado: (2011)

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Clozapine: Current perspective
por: Solanki, Ram K., et al.
Publicado: (2007)

Clozapine associated thrombocytopenia
por: Kate, Natasha, et al.
Publicado: (2013)

Rhabdomyolysis in Clozapine Overdose
por: Jansman, Frank G. A., et al.
Publicado: (2015)

Clozapine for mitochondrial psychosis()
por: Finsterer, Josef, et al.
Publicado: (2017)

Clozapine-induced myocarditis
por: Datta, Tanuka, et al.
Publicado: (2018)

Clozapine Use in Adolescents
por: Praharaj, Samir Kumar
Publicado: (2017)

Clozapine-induced agranulocytosis
por: Mijovic, Aleksandar, et al.
Publicado: (2020)

Clozapine-induced seizure
por: Borah, Ankur Jyoti, et al.
Publicado: (2019)

Clozapine augmentation strategies
por: Roerig, James L.
Publicado: (2019)

Clozapine and COVID-19
por: Silva, Edward, et al.
Publicado: (2020)

Clozapin-Update 2022
por: Qubad, Mishal, et al.
Publicado: (2022)

Clozapine and urinary incontinence
por: Osca Oliver, A., et al.
Publicado: (2022)

Clozapine & constipation: an audit of bowel habit monitoring and laxative prescribing in inpatients on clozapine
por: Boyd, Holly, et al.
Publicado: (2021)

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice
por: Manvich, Daniel F., et al.
Publicado: (2018)

Feasibility and reliability of point-of-care pocket-sized echocardiography
por: Andersen, Garrett Newton, et al.
Publicado: (2011)

Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
por: Rodriguez, Victoria, et al.
Publicado: (2020)

Clozapine: Drowsiness with markedly increased hypersalivation and myoclonus secondary to clozapine toxicity: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8da18aquafmfq62klk1icqhq8i